Meranda Parascandola – Page 3

July 19, 2019

Published by Meranda Parascandola at July 19, 2019

One Giant Leap for Mankind. The Original Moonshot.

Fifty years ago, tomorrow, astronauts walked on the moon for the first time. Apollo 11’s success—just 66 years after the Wright brothers’ first flight—showcased humankind’s moxie and ingenuity. Now the moon is in our sights again, for a generation that will test where science meets profit.

July 31, 2019

Published by Meranda Parascandola at July 31, 2019

CMC Regulatory Is the Ringo Starr of Regulatory Affairs

Always present, rarely seen, and increasingly essential, the fast-growing area of Chemistry, Manufacturing and Controls (CMC) of pharmaceutical products is slowly emerging as a titan in its own right.

August 15, 2019

Published by Meranda Parascandola at August 15, 2019

DSI to Showcase Progressive Drug Development Strategies and Products at the 2019 Biotech Week Boston

DSI will be attending Biotech Week Boston 2019, find us at BioPharm America on September 09-12th. Biotech Week Boston is dedicated to accelerating the business of biotechnology through new ideas, science, technology and partnerships to make a positive impact on patient health.

August 21, 2019

Published by Meranda Parascandola at August 21, 2019

Key Elements of a CMC Strategic Development Plan

How to Avoid the End-of-Summer Slump Getting your productivity back on track requires using your energy wisely, whether it's stockpiled from vacation or running on fumes. Here are a few ways to turn the end of summer into a springboard for a productive Autumn.

September 19, 2019

Published by Meranda Parascandola at September 19, 2019

What Would Bruce Lee Do?

How would Bruce Lee develop a viable and effective chemistry, manufacturing and controls (CMC) regulatory strategy while focusing on ensuring a viable and effective clinical development strategy to keep the product moving forward, when the odds of clinical success were against him?

September 20, 2019

Published by Meranda Parascandola at September 20, 2019

DSI Expert James Mencel to present at AMRI Symposium reACTION 2019

Drug Substance Development Expert, Dr. James Mencel, will be presenting “Expedited Filings and their CMC Implications: Considerations toward Better Planning”, sponsored by AMRI, a global contract research and manufacturing organization. Conference sessions will occur at AMRI’s Corporate Headquarters.